Tooba Ghazanfari

Dr. Tooba Ghazanfari

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SGSara Ghaffarpour
Sara Ghaffarpour
TGTooba Ghazanfari
Tooba Ghazanfari
SASussan Kaboudanian Ardestani
Sussan Kaboudanian Ardestani
MNMohammad Mehdi Naghizadeh
Mohammad Mehdi Naghizadeh
MMMohammad Reza Vaez Mahdavi
Mohammad Reza Vaez Mahdavi
HKHossein Ali Khazaei
Hossein Ali Khazaei
The outcome of the immune response depends on the content and magnitude of inflammatory mediators, the right time to start, and the duration of inflammatory responses. Patients with coronavirus disease 2019 (COVID-19) represent diverse disease severity. Understanding differences in immune responses in individuals with different disease severity levels can help elucidate disease mechanisms. Here, we serially analyzed the cytokine profiles of 809 patients with mild to critical COVID-19. The cytokine profile revealed an overall increase in IL-1β, IL-1Ra, TNF-α, IL-6, IL-2, IL-8, and IL-18 and impaired production of IFN-α and -β. Only an early rise in IL-1Ra, IL-6, and IL-2 levels was linked to worse disease outcomes. On the other hand, long-term rises in IL-1β, IL-1Ra, TNF-α, IL-6, IL-2, IL-8, and IL-18 levels were linked to worse disease outcomes. Principal component analysis identified a component, including IL-1β, TNF-α, IFN-α, and IL-12, that was associated with disease severity. Spearman analysis revealed that the correlation of IL-1β and IFN-α was entirely different between mild and critical patients. Therefore, the ratio of IL-1β to IFN-α seemed to be a suitable criterion for distinguishing critical patients from mild ones. The higher levels of the IL-1β to IFN-α ratio correlated with improved outcomes. These data point to an imbalance of IL-1β/IFNα, contributing to hyperinflammation in COVID-19.

1 December 2009 in International Immunopharmacology
Verified
Journal Article
Closed access
RYRoya Yaraee
Roya Yaraee
TGTooba Ghazanfari
Tooba Ghazanfari
MEMasoumeh Ebtekar
Masoumeh Ebtekar
SASussan K. Ardestani
Sussan K. Ardestani
ARAbbas Rezaei
Abbas Rezaei
ZHZuhair M. Hassan
Zuhair M. Hassan

7 November 2000 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
TGTooba Ghazanfari
Tooba Ghazanfari
ZHZ. M. Hassan
Z. M. Hassan
MEMasoumeh Ebtekar
Masoumeh Ebtekar
AAA. Ahmadiani
A. Ahmadiani
GNG. Naderi
G. Naderi
AAA. Azar
A. Azar
The regulation of T helper (Th)1‐ and Th2‐type cytokine patterns is important in the final outcome of leishmaniasis in human and murine models. We examined the efficacy of garlic therapy or a combination of garlic and an antimonial drug (glucantime) in promoting healing and regulation of Th1/Th2 cytokine patterns in highly susceptible BALB/c mice infected with Leishmania major. Separate groups of infected mice received 20 mg/kg/day garlic, 60 mg/kg/day glucantime or a combination of the two, from day 30 after infection for 2 weeks. An enzyme‐linked immunosorbant assay ( ELISA) was performed on spleen cell culture supernatants for interferon(IFN)‐γ interleukin(IL)‐2, IL‐4 and IL‐10. The results indicate that garlic therapy is more effective than the usual antileishmanial drug in curing the infection. Garlic‐treated mice developed Th1‐type cytokine responses. In contrast, glucantime therapy led to a Th2‐type response in the control group with a lower level of IL‐2. However, a combination of garlic and glucantime treatment was more effective than either treatment alone, and resulted in a Th1‐type response similar to that which developed with garlic treatment. These results suggest that garlic extract in combination with an antimonial drug, may provide effective therapy against L. major. The immunomodulatory properties of garlic were elucidated in terms of shifting the cytokine response to a Th1‐type pattern and therefore causing the protective response.

20 February 2006 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
TGTooba Ghazanfari
Tooba Ghazanfari
ZHZuhair M. Hassan
Zuhair M. Hassan
AKAli Khamesipour
Ali Khamesipour

7 April 2010 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
PDF file
ZSZeinab Shavandi
Zeinab Shavandi
TGTooba Ghazanfari
Tooba Ghazanfari
KMKiumarz Nazari Moghaddam
Kiumarz Nazari Moghaddam
Silver nanoparticles, the new generation of antimicrobial agents, are becoming one of the progressively growing products in nanotechnology. Meanwhile, the potential side effects of these nanoparticles have not been studied thoroughly yet. Macrophages, one of the most important immune cells in innate and acquired immune responses, are a key component of the clearance mechanisms in semi-open interfaces of human body against nanosilver (nano-Ag). In this experimental study, we assessed the effect of commercial colloidal nano-Ag on murine peritoneal macrophages by MTT and nitric oxide (NO) production assay in vitro. A significant decrease in cell viability was observed for 1 ppm (part per million) to 25 ppm of nano-Ag concentrations compared to the control group (P < 0.01) after 24 h of cell culture. Also, a significant decrease in the cell viability was observed for 2–25 ppm of nano-Ag concentrations after 48–72 h, respectively (P < 0.05). In our study, exposure to 0.4–25 ppm of colloidal nano-Ags brought about a considerable decline (P < 0.05) in NO production by macrophages. Nevertheless, there is no evidence of substantial difference at lower concentrations. This acute cytotoxic dose-dependent effect of nano-Ag particles on peritoneal macrophages which declines cell viability and NO production urges caution about the usage for sensitive surfaces. It is highly recommended to carry out the in vivo investigation for human to confirm its use.

1 January 2008 in Cutaneous and Ocular Toxicology
Verified
Journal Article
Closed access
HGHassan Ghasemi
Hassan Ghasemi
TGTooba Ghazanfari
Tooba Ghazanfari
MBMahmoud Babaei
Mahmoud Babaei
MSMohammad Reza Soroush
Mohammad Reza Soroush
RYRoya Yaraee
Roya Yaraee
SFSoghrat Faghihzadeh
Soghrat Faghihzadeh
Eyes are very sensitive to sulfur mustard (SM) gas because they have wet surfaces. The severity of ocular damage is related to the dose and duration of exposure to SM, and recovery may take up to several years after the exposure. We conducted a large cohort study to evaluate the ocular signs and symptoms of 367 chemical war victims in Sardasht City, Iran, 20 years after their exposure to mustard gas. The results of these chemical war victims (i.e., the cases) were compared with the results for 128 unaffected civilians (i.e., the controls). Photophobia was the most significant symptom in the cases (36.8%) (compared with 20.3% in the controls) (p ≤ .001). Ocular surface discomfort (burning, itching, and redness) was the second most significant symptom in the cases (29.2%) (compared with 19.5% in the controls) (p=.034). Other symptoms such as foreign-body sensation, tearing, pain, blurring of vision, and dry eye sensation were not significantly different between the 2 groups. In the slit-lamp findings, bulbar conjunctival abnormality was the most significant sign in the cases (9.3%) (compared with 1.6% in the controls) (p=.004). Limbal tissue changes were the second most significant sign in the cases (3.0%) (compared with 0.0% in the controls) (p=.048). Other slit-lamp findings related to tearing and abnormalities in the lids and cornea were not significantly different between the 2 groups. Our findings in the present study showed that photophobia and ocular surface discomfort (burning, itching, and redness) were the most significant symptoms. In addition, bulbar conjunctival abnormalities and limbal tissue changes were the most significant signs among the sulfur mustard chemical war victims.